The following proposals are examples of the recent research grants

Arizona State University $186,374 for the study of synthetic peptide-DNA antibodies for targeting cancer cells
Columbia University $141,320 for the study of developing simple prognostic indicators of chemotherapy response in cutaneous T-cell lymphoma
Johns Hopkins University $158,492 for the study of sticky nanoparticles for selective targeting of triple negative breast cancer
Sidney Kimmel Cancer Center $184,575 for the development of an immunogenomic liquid molecular assay of response to immunotherapy
University of Texas, MD Anderson Cancer Center $156,749 for the study of ERK inhibitor efficacy and resistance in colorectal cancer
University of Texas Health Science Center, San Antonio $169,842 for the study of KDM1A inhibition enhances ERB mediated tumor suppression in ovarian cancer
Wright State University $149,111 for studying the impact of platelet-activating factor in targeted therapy responses in melanoma patients